Grant: Dissemination Events - PA: Musculoskeletal Hlth, Arthritis, Skin & Oral Health
Ottawa Hospital Research Institute
$20,000.00
The Ottawa Conference on New Directions in Biology & Disease of Skeletal Muscle
EF 2009-10
Résumé
In May 2007, we hosted the first Ottawa Conference on Neuromuscular Disease, which spanned three days, featured eight scientific sessions and over 30 local, national and international scientific speakers. By all accounts, the meeting was a resounding success. The 2nd Ottawa Conference on Neuromuscular Disease, May 5-8, 2010, will be held jointly with the semi-annual "New Directions in Biology & Disease of Skeletal Muscle" meeting. Combining the two meetings not only avoids duplicate effort and the potential competition for attendees, but will draw additional scientists and trainees to the Ottawa Conference that might not otherwise attend. "The Ottawa Conference on New Directions in Biology & Disease of Skeletal Muscle", to be held at the Westin Hotel (Ottawa), will highlight current developments in muscle biology, disease, and therapy. The Conference is divided into seven scientific sessions spanning three days, with over 30 speakers from North American and abroad. We also have two Keynote speakers Drs. Eric Olson and Andrew Marks, and, in collaboration with the Muscular Dystrophy Association (MDA-USA), we are holding a special round-table discussion session on challenges facing development of novel therapeutics for treating neuromuscular disease. We anticipate ~300 attendees. The total cost of the meeting will be approximately $200,000, half of which will be recovered through our registration fee. The remaining funds will be obtained from various sources including national and international granting and charitable agencies, and local research and educational institutes. The money obtained from this CIHR application will be used to off-set some of the costs of travel and accommodation for our invited speakers. We have ample experience to successfully organize and host the May 2010 meeting. We believe the combined meeting is well-set to accomplish its goals, and will provide an excellent forum for scientific discussion and interaction.
Programme
Dissemination Events - PA: Musculoskeletal Hlth, Arthritis, Skin & Oral Health
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
204361
Name
Kothary Rashmi K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Dissemination Events Grants
Projecttitle
The Ottawa Conference on New Directions in Biology & Disease of Skeletal Muscle
Programtype2
Miscellaneous Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Dissemination Events - PA: Musculoskeletal Hlth, Arthritis, Skin & Oral Health
Keyworddelim
Genetics; Muscle Biology; Neuromuscular; Skeletal Muscle
Abstract
In May 2007, we hosted the first Ottawa Conference on Neuromuscular Disease, which spanned three days, featured eight scientific sessions and over 30 local, national and international scientific speakers. By all accounts, the meeting was a resounding success. The 2nd Ottawa Conference on Neuromuscular Disease, May 5-8, 2010, will be held jointly with the semi-annual "New Directions in Biology & Disease of Skeletal Muscle" meeting. Combining the two meetings not only avoids duplicate effort and the potential competition for attendees, but will draw additional scientists and trainees to the Ottawa Conference that might not otherwise attend. "The Ottawa Conference on New Directions in Biology & Disease of Skeletal Muscle", to be held at the Westin Hotel (Ottawa), will highlight current developments in muscle biology, disease, and therapy. The Conference is divided into seven scientific sessions spanning three days, with over 30 speakers from North American and abroad. We also have two Keynote speakers Drs. Eric Olson and Andrew Marks, and, in collaboration with the Muscular Dystrophy Association (MDA-USA), we are holding a special round-table discussion session on challenges facing development of novel therapeutics for treating neuromuscular disease. We anticipate ~300 attendees. The total cost of the meeting will be approximately $200,000, half of which will be recovered through our registration fee. The remaining funds will be obtained from various sources including national and international granting and charitable agencies, and local research and educational institutes. The money obtained from this CIHR application will be used to off-set some of the costs of travel and accommodation for our invited speakers. We have ample experience to successfully organize and host the May 2010 meeting. We believe the combined meeting is well-set to accomplish its goals, and will provide an excellent forum for scientific discussion and interaction.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kothary, Rashmi K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $20,000~ $0~